1. VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer Patients
   Ah-Young Kwon et al, 2015, Stem Cells and Development CrossRef
2. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer
   LINGLING HU et al, 2015 CrossRef
3. null
   Lori E. Lowes et al, 2017 CrossRef
4. A 10-gene expression signature of Notch pathway predicts recurrence in ovarian carcinoma
   FANG CHEN et al, 2015 CrossRef
5. TNF receptor-associated factor 1 as a biomarker for assessment of non-small cell lung cancer metastasis and overall survival
   Xiaoxing Wen et al, 2018, Clin Respir J CrossRef
6. TRAF1 Is Critical for DMBA/Solar UVR-Induced Skin Carcinogenesis
   Hiroyuki Yamamoto et al, 2017, Journal of Investigative Dermatology CrossRef
7. Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines
   Brittany A. Avin et al, 2019, Genes Chromosomes Cancer CrossRef
8. null
   Rokas Miksiunas et al, 2019 CrossRef
9. Hydroxychavicol from Piper betle induces apoptosis, cell cycle arrest, and inhibits epithelial-mesenchymal transition in pancreatic cancer cells
   Ananda Guha Majumdar et al, 2019, Biochemical Pharmacology CrossRef
10. Chemotherapy Resistance in Advanced Ovarian Cancer Patients
    Ruchika Pokhriyal et al, 2019, Biomark�Cancer CrossRef
11. LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
    Ran Cui et al, 2019, Cancer Cell Int CrossRef
12. CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin
    Jeanne Galaine et al, 2019, Int. J. Cancer CrossRef
13. E2F1: a promising regulator in ovarian carcinoma
    Lei Zhan et al, 2016, Tumor Biol. CrossRef
14. Sox10 expression in ovarian epithelial tumors is associated with poor overall survival
    Ah-Young Kwon et al, 2016, Virchows Arch CrossRef
15. EMT promoting transcription factors as prognostic markers in human breast cancer
    Magdalena Matysiak et al, 2017, Arch Gynecol Obstet CrossRef
16. Extracellular Matrix Alterations in Metastatic Processes.
    Mayra Paolillo, 0 CrossRef
17. Big data-based identification of methylated genes associated with drug resistance and prognosis in ovarian cancer
    Bingbing Yan et al, 2020 CrossRef
18. TERT-Regulation and Roles in Cancer Formation.
    Marta Dratwa et al, 2020, Front Immunol CrossRef
19. EMT-related genes are unlikely to be involved in extracapsular growth of lymph node metastases in gastric cancer
    Elise Pretzsch et al, 2021, Pathology - Research and Practice CrossRef
20. FOXA1 can be modulated by HDAC3 in the progression of epithelial ovarian carcinoma
    Tong Lou et al, 2022, J Transl Med CrossRef
21. 3D Hydrogel-based microcapsules as an in vitro model to study tumorigenicity, cell migration and drug resistance
    Özlem Ertekin et al, 2022, Acta Biomaterialia CrossRef
22. Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
    Mukulika Bose et al, 2022, Front. Cell Dev. Biol. CrossRef
23. Roles of GFPT2 Expression Levels on the Prognosis and Tumor Microenvironment of Colon Cancer
    Xiaorong Ding et al, 2022, Front. Oncol. CrossRef
24. NSD1 Mutations in Sotos Syndrome Induce Differential Expression of Long Noncoding RNAs, miR646 and Genes Controlling the G2/M Checkpoint
    Giuseppina Conteduca et al, 2022, Life CrossRef
25. Construction of Metastasis-Specific Regulation Network in Ovarian Cancer Based on Prognostic Stemness-Related Signatures
    Wenwen Wang et al, 2023, Reprod. Sci. CrossRef
26. RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis
    Hui Yao et al, 2023, Cell Oncol. CrossRef
27. Oncogene goosecoid is transcriptionally regulated by E2F1 and correlates with disease progression in prostate cancer
    Yue Ge et al, 2023 CrossRef